A Pilot Study of Oraxol in Subjects With Cutaneous Angiosarcoma
Phase of Trial: Phase I
Latest Information Update: 29 Nov 2018
At a glance
- Drugs Paclitaxel (Primary)
- Indications Haemangiosarcoma
- Focus Therapeutic Use
- Sponsors Athenex
- 20 Nov 2018 Planned primary completion date changed from 1 Jul 2020 to 1 Aug 2020.
- 20 Nov 2018 Status changed from not yet recruiting to recruiting.
- 06 Jun 2018 New trial record